Johnson & Johnson (JNJ)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 14,066,000 14,684,000 38,018,000 38,476,000 35,153,000 34,624,000 13,054,000 12,724,000 17,941,000 19,157,000 18,366,000 19,830,000 20,878,000 17,880,000 17,767,000 15,115,000 14,714,000 16,986,000 15,185,000 17,166,000
Total stockholders’ equity US$ in thousands 71,490,000 70,158,000 71,538,000 70,020,000 68,774,000 71,228,000 75,149,000 70,869,000 76,804,000 74,599,000 76,357,000 74,709,000 74,023,000 70,272,000 69,580,000 65,834,000 63,278,000 64,473,000 62,978,000 61,294,000
ROE 19.68% 20.93% 53.14% 54.95% 51.11% 48.61% 17.37% 17.95% 23.36% 25.68% 24.05% 26.54% 28.20% 25.44% 25.53% 22.96% 23.25% 26.35% 24.11% 28.01%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $14,066,000K ÷ $71,490,000K
= 19.68%

Johnson & Johnson's return on equity (ROE) has shown some fluctuations over the past few years. The ROE was relatively high at the beginning of the period, reaching 28.01% as of March 31, 2020. However, there was a decline in ROE to 23.25% by the end of December 2020.

Throughout 2021 and the first half of 2022, the ROE improved gradually, reaching a peak of 28.20% by the end of December 2021. This indicates that the company was efficiently utilizing its equity to generate profits during this period.

From March 2023 to June 2024, there was a significant drop in ROE, falling to as low as 17.37% in June 2023. However, the ROE saw a notable increase in the third quarter of 2023, reaching 48.61%, and remained at high levels until the first half of 2024, with values above 50%.

The decrease in ROE towards the end of 2024, dropping to 19.68% by December 31, 2024, may indicate a decrease in profitability relative to the equity. It is important for stakeholders to monitor the ROE closely as it provides insights into the company's ability to generate returns on the shareholders' equity invested in the business.


See also:

Johnson & Johnson Return on Equity (ROE) (Quarterly Data)